Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-21

Clinical Trial Update: Efficiency of Bumetanide in Autistic Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of bumetanide in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

Sponsor: University Hospital, Brest | Conditions: Autistics Children | Phase 3 | Status: COMPLETED